Company PCL, Inc.

Stocks

A241820

KR7241820000

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2025-03-21			5-day change	1st Jan Change
6,040.00 ^KRW	-1.63%		-.--%	-

24-12-29	Yeom Ju-hwan agreed to acquire 36.90% stake in mCureX Therapeutics, Inc. from PCL, Inc. for KRW 13.0 billion.	CI
24-08-29	PCL, Inc. announced that it has received KRW 4.004999835 billion in funding	CI

Business description: PCL, Inc.

PCL Inc is a Korea-based company principally engaged in development and manufacture of vitro diagnostic medical device for immunological diagnosis. The Companyâ€™s products include blood bank screening products and quick diagnostic products. And the Company also provides platform services.

Number of employees: 31

Sales by Activity: PCL, Inc.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
Vitro Diagnostics-Related Business	53.68B	46.15B	37.22B	8.43B	1.25B

See all business segments

Geographical breakdown of sales: PCL, Inc.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
South Korea	3.91B	599M	28.13B	2.92B	1.17B
Other	-	-	-	138M	34.09M
Asia	-	-	-	3.87B	19.75M
Europe	-	-	-	1.48B	-
Overseas	49.77B	45.55B	9.08B	-	-

See all geographic segments

Executive Committee: PCL, Inc.

Manager	Title	Age	Since
So-Yeon Kim CEO	Chief Executive Officer	55	-
Seong-Woo Lee SAM	Sales & Marketing	42	2024-03-27
Mu-Yong So AUD	Comptroller/Controller/Auditor	53	2024-03-27
Won-Hee Jang AUD	Comptroller/Controller/Auditor	53	2025-03-30
Seung-Ki Hong AUD	Comptroller/Controller/Auditor	72	-

See PCL, INC. governance

Composition of the Board of Directors: PCL, Inc.

Director	Title	Age	Since
Chul-Joon Kim BRD	Director/Board Member	73	-
So-Yeon Kim BRD	Director/Board Member	55	-
Mu-Yong So BRD	Director/Board Member	53	2024-03-27
Seong-Woo Lee BRD	Director/Board Member	42	2024-03-27
Dae-Yeol Kim BRD	Director/Board Member	49	2023-03-30

Composition of the Board of Directors

Shareholders: PCL, Inc.

Name	Stocks	%	Valuation
So-Yeon Kim 0.8415 %	497,910	0.8415 %	105 193 ₩
OLIX PHARMACEUTICALS, INC 0.2348 %	138,962	0.2348 %	29 359 ₩
In-gyu Kim 0.0191 %	11,284	0.0191 %	2 384 ₩
Ji-won Lee 0.004958 %	2,934	0.004958 %	620 ₩
Seung-hyun Lee 0.004958 %	2,934	0.004958 %	620 ₩

List of PCL, INC. shareholders

Company details: PCL, Inc.

PCL, Inc.

99 Digital-ro 9-gil

08510, Seoul

http://www.pclchip.com

Bio Diagnostics & Testing

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PCL, INC.	-1.63%	-.--%	-.--%	-86.40%	11.19M
VERACYTE, INC.	-3.93%	-0.19%	+110.38%	+108.07%	4.55B
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-3.39%	-0.61%	+78.17%	+203.46%	3.37B
BGI GENOMICS CO., LTD.	+4.20%	-1.15%	-27.01%	-39.95%	2.05B
IOVANCE BIOTHERAPEUTICS, INC.	-3.20%	-1.86%	+126.20%	-46.66%	1.89B
CAREDX, INC.	-2.06%	-2.33%	+41.63%	+175.73%	1.47B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+2.01%	+0.83%	+123.08%	-50.04%	898M
SEEGENE, INC.	+6.42%	-1.19%	-10.08%	+43.92%	880M
CURIOX BIOSYSTEMS CO., LTD	+7.05%	+1.07%	-2.63%	-	487M
HANGZHOU ALLTEST BIOTECH CO., LTD.	+1.63%	-3.18%	-36.79%	-18.41%	483M
Average	+0.71%	-1.07%	+40.29%	+32.19%	1.61B
Weighted average by Cap.	-1.13%	-0.66%	+67.89%	+80.11%